Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
1.6400
+1.1700 (248.94%)
NASDAQ · Last Trade: Oct 18th, 1:08 PM EDT
Detailed Quote
Previous Close
0.4700
Open
1.370
Bid
1.740
Ask
1.750
Day's Range
1.130 - 2.390
52 Week Range
0.3870 - 2.810
Volume
492,838,736
Market Cap
41.39M
PE Ratio (TTM)
-1.802
EPS (TTM)
-0.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
21,688,307
Chart
About Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
Rani Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative oral therapies for the delivery of biologics, such as peptides and proteins, which traditionally require injection for administration. The company’s proprietary RaniPill platform utilizes a novel approach to encapsulate and deliver these treatments orally, aiming to enhance patient compliance and accessibility in the administration of complex medications. By combining advanced engineering with pharmaceutical expertise, Rani Therapeutics is exploring solutions that could revolutionize the landscape of therapeutic delivery, making it more patient-friendly. Read More
Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) successfully closed of its strategic land acquisition from Li-FT Power Ltd. (TSXV: LIFT | OTCQX: LIFFF) adding a massive 313 mineral claims totaling 167 km² to its already dominant position in the polymetallic-rich Nisk region of Quebec.
